Table 2. Univariate and multivariate Cox regression analyses on patient survivals.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95%CI | p value | Hazard ratio | 95%CI | p value | |
| Sex | ||||||
| Female | Reference | Reference | ||||
| Male | 4.44 | (0.97–20.25) | 0.055 | |||
| Age | 1.08 | (1.05–1.12) | <0.001** | 1.07 | (1.01–1.13) | 0.013* |
| Crescents | ||||||
| 0 | Reference | Reference | Reference | Reference | ||
| 1 | 3.93 | (1.18–13.07) | 0.025* | 5.75 | (1.14–29.05) | 0.034* |
| Albumin | 0.23 | (0.11–0.50) | <0.001** | 0.38 | (0.05–3.09) | 0.367 |
| Total protein | 0.46 | (0.28–0.75) | 0.002** | 0.85 | (0.22–3.22) | 0.809 |
| Low-density lipoprotein | 0.99 | (0.97–1.00) | 0.154 | |||
| High-density lipoprotein | 0.95 | (0.91–0.99) | 0.009** | 0.94 | (0.90–0.99) | 0.026* |
| Daily urine protein | 1.14 | (1.01–1.29) | 0.038* | 0.97 | (0.78–1.20) | 0.771 |
| Urinary protein/creatinine ratio | 1.07 | (1.02–1.12) | 0.003** | |||
| IgG | 1.00 | (1.00–1.00) | 0.398 | |||
| IgM | 0.98 | (0.96–1.00) | 0.036* | 0.99 | (0.97–1.02) | 0.453 |
| IgA | 1.00 | (1.00–1.00) | 0.075 | |||
| C3 | 0.98 | (0.95–1.00) | 0.094 | |||
| C4 | 1.02 | (0.97–1.07) | 0.447 | |||
| Blood urea nitrogen | 1.02 | (1.01–1.03) | 0.005** | |||
| Creatinine | 1.06 | (0.96–1.17) | 0.277 | |||
| eGFR | 0.97 | (0.94–0.99) | 0.011* | 1.00 | (0.96–1.03) | 0.915 |
| ANA | ||||||
| Negative | Reference | Reference | ||||
| Positive | 1.56 | (0.19–12.84) | 0.678 | |||
| ANCA | ||||||
| Negative | Reference | Reference | ||||
| Positive | 7.59 | (0.88–65.49) | 0.065 | |||
Cox proportional hazard regression.
*p<0.05,
**p<0.01.